Webcast News

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval of YARTEMLEA® (narsoplimab-wuug), the first and only therapy indicated for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). To ensure broad participation following this significant milestone — and to accommodate shareholders’ and investors’ holiday schedules — the call will now take place on Wednesday, January 7,...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2025 before the market opens on Thursday, January 29, 2026, and will hold a conference call on the same day at 8:30 a.m. ET. During the call, the company will discuss its financial performance, as well as future expectations. The call will be webcast live on the “Investors” section of our websit...

NEW YORK--(BUSINESS WIRE)--Spotify Technology S.A. (NYSE: SPOT) will post its fourth quarter 2025 results and deck to shareholders on Tuesday, February 10, 2025 before market open. The company will hold a question and answer session to discuss fourth quarter 2025 results at 8:00 am Eastern Time. Management will answer questions submitted via Slido. Questions may be submitted on the day of the call at www.slido.com using the event code #SpotifyEarningsQ425. A live webcast of the earnings call wi...

DALLAS--(BUSINESS WIRE)--Resources Connection, Inc. (Nasdaq: RGP) (the “Company,” “we,” and “our”), a global consulting firm, will announce results of operations for its second quarter of fiscal 2026 ended November 29, 2025, after the close of market on Wednesday, January 7, 2026. This release will be followed by a conference call at 5:00 p.m. ET, January 7, 2026. A live webcast of the call will be available on the “Investor Relations” Events section of the Company’s website. To access the call...

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA), an often-fatal complication of stem-cell transplantation driven by activation of the lectin pathway of complement. YARTEMLEA is the first and only approved lectin pathway inhibitor. YARTEMLEA selectively inhibits MASP-2, the ef...

GOLDEN, Colo.--(BUSINESS WIRE)--Good Times Restaurants Inc. (Nasdaq: GTIM), operator of Bad Daddy’s Burger Bar and Good Times Burgers & Frozen Custard, today reported financial results for the fiscal fourth quarter and fiscal year ended September 30, 2025. Highlights of the Company’s financial results include: Total Revenues decreased 0.5% to $141.6 million for the year compared to the previous fiscal year. Total Restaurant Sales for Good Times restaurants were $39.2 million for the year an...

SANTA PAULA, Calif.--(BUSINESS WIRE)--Limoneira Company (the “Company” or “Limoneira”) (Nasdaq: LMNR), a diversified lemon and avocado growing and lemon packing company with related agribusiness activities and real estate development operations, today reported financial results for the fiscal fourth quarter and full year ended October 31, 2025. The Company continues to execute on its value creation strategy of growing agriculture income and monetizing land and water assets. Agriculture initiati...

BOISE, Idaho--(BUSINESS WIRE)--Albertsons Companies, Inc. will release financial results for the third quarter of fiscal 2025, before the market opens on Wednesday, Jan. 7, 2026....

SAN JUAN, Puerto Rico--(BUSINESS WIRE)--First BanCorp (the “Corporation”) (NYSE: FBP), the bank holding company for FirstBank Puerto Rico, announced today that it expects to report its financial results for the fourth quarter ended December 31, 2025, before the market opens on January 27, 2026. First BanCorp will hold a conference call and live webcast to discuss the financial results at 10:00am Eastern Time on Tuesday, January 27, 2026. The call and webcast will be broadcast live over the inte...

LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco. Vladimir Makatsaria, Chief Executive Officer of LivaNova, and Alex Shvartsburg, Chief Financial Officer, will participate in a fireside chat on Wed., Jan. 14, 2026, at 1:30 p.m. Pacific Standard Time. The discussion will be available to all interested parties who register to attend the webcast, w...